cromakalim has been researched along with Angiospasm, Intracranial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahams, JM; Chen, W; Jhanwar-Uniyal, M; Murali, R; Omeis, I; Rozental, R | 1 |
| Bari, F; Boda, K; Busija, DW; Domoki, F; Institoris, A; Katakam, PV; Snipes, JA | 1 |
| Chen, EF; Howng, SL; Kassell, NF; Kwan, AL; Lee, KS; Lin, CL; Wu, CS | 1 |
3 other study(ies) available for cromakalim and Angiospasm, Intracranial
| Article | Year |
|---|---|
Prevention of cerebral vasospasm by local delivery of cromakalim with a biodegradable controlled-release system in a rat model of subarachnoid hemorrhage.
Topics: Absorbable Implants; Animals; Cromakalim; Drug Delivery Systems; Hyaluronic Acid; Male; Potassium Channels; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2009 |
Impaired vascular responses of insulin-resistant rats after mild subarachnoid hemorrhage.
Topics: Acetylcholine; Animals; Cerebrovascular Circulation; Cromakalim; Cyclooxygenase 2; Disease Models, Animal; Insulin Resistance; Nitroprusside; Obesity; Rats; Rats, Zucker; Subarachnoid Hemorrhage; Vasodilation; Vasodilator Agents; Vasospasm, Intracranial | 2011 |
Delayed administration of the K+ channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
Topics: Animals; Cromakalim; Dose-Response Relationship, Drug; Drug Administration Schedule; Intracranial Aneurysm; Rabbits; Subarachnoid Hemorrhage; Time Factors; Vasodilator Agents; Vasospasm, Intracranial | 2000 |